A Randomised Phase II Feasibility Study of Docetaxel (Taxotere®) Plus Prednisolone vs. Docetaxel (Taxotere®) Plus Prednisolone Plus Zoledronic Acid (Zometa®) vs. Docetaxel (Taxotere®) Plus Prednisolone Plus Strontium-89 vs. Docetaxel (Taxotere®) Plus Prednisolone Plus Zoledronic Acid (Zometa®) Plus Strontium-89 in Hormone Refractory Prostate Cancer Metastatic to Bone.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT00554918

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:35:28.039854+00:00

Published At

2013-08-07T00:00:00+00:00

Record Updated At

2013-08-07

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Metastatic Cancer", "Prostate Cancer"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2013-08-07"

protocolSection.identificationModule.nctId

"NCT00554918"

protocolSection.identificationModule.officialTitle

"A Randomised Phase II Feasibility Study of Docetaxel (Taxotere\u00ae) Plus Prednisolone vs. Docetaxel (Taxotere\u00ae) Plus Prednisolone Plus Zoledronic Acid (Zometa\u00ae) vs. Docetaxel (Taxotere\u00ae) Plus Prednisolone Plus Strontium-89 vs. Docetaxel (Taxotere\u00ae) Plus Prednisolone Plus Zoledronic Acid (Zometa\u00ae) Plus Strontium-89 in Hormone Refractory Prostate Cancer Metastatic to Bone."

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Metastatic Cancer (protocolSection.conditionsModule.conditions)
• Prostate Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.